Brunswick Corp/ US1170431092 /
2024-05-13 9:59:29 PM | Chg. +0.03 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
83.44USD | +0.04% | 16,611 Turnover: 1.4 mill. |
-Bid Size: - | -Ask Size: - | 5.64 bill.USD | 1.92% | 13.92 |
GlobeNewswire
2:00 AM
HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- an...
GlobeNewswire
2:00 AM
HUTCHMED Initiates Phase II/III Trial of the Combination of Surufatinib and Camrelizumab for Treatme...
GlobeNewswire
05-13
Inventiva announces the publication in Nature Communications of additional results from NATIVE Phase...
GlobeNewswire
05-08
HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee
GlobeNewswire
05-07
Critter Control, the Nation’s Largest Nuisance Wildlife Removal Company, Announces the Opening of it...
Newsfile Corp
05-02
THE Mining Investment Event of the North, Quebec City - June 4-6, 2024 Welcomes Keynote Speaker Jenn...
GlobeNewswire
05-01
DatChat to Participate in Upcoming EF Hutton Annual Global Conference on May 15th in New York City
GlobeNewswire
04-26
HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorecta...
GlobeNewswire
04-25
Three-quarters of New Jerseyans Familiar With Proper Guidelines to Store and Dispose of Medications,...
GlobeNewswire
04-25
Puma Exploration Launches Drone High-Resolution Magnetic Survey at Williams Brook
GlobeNewswire
04-24
Challenged Athletes Foundation and Össur Amplify Support for Athletes with Limb Loss and Limb Differ...
GlobeNewswire
04-23
1Kosmos Zero Trust Solutions Now Available on Carahsoft GSA Schedule and Additional Contract Vehicle...